KCTD16 Antikörper (AA 301-400) (Cy7)
Kurzübersicht für KCTD16 Antikörper (AA 301-400) (Cy7) (ABIN6986288)
Target
Alle KCTD16 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 301-400
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat,Cow
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human KCTD16
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- KCTD16 (Potassium Channel Tetramerisation Domain Containing 16 (KCTD16))
-
Andere Bezeichnung
- KCTD16
-
Hintergrund
-
Synonyms: BTB/POZ domain containing protein KCTD16, BTB/POZ domain-containing protein KCTD16, DKFZp781A1155, KCD16_HUMAN, KCTD16, KIAA1317, MGC138167, Potassium channel tetramerisation domain containing 16, Potassium channel tetramerization domain containing protein 16, Potassium channel tetramerization domain-containing protein 16, RGD1559856.
Background: Auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. Increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization.
-
Gen-ID
- 57528
-
UniProt
- Q68DU8
-
Pathways
- Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-